COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

被引：0

作者：

Anne H. Cross

Silvia Delgado

Mario Habek

Maria Davydovskaya

Brian J. Ward

Bruce A. C. Cree

Natalia Totolyan

Ratnakar Pingili

Linda Mancione

Xixi Hu

Roseanne Sullivan

Wendy Su

Ronald Zielman

Ayan Das Gupta

Xavier Montalban

Kevin Winthrop

机构：

[1] Washington University,Department of Neurology

[2] University of Miami Miller School of Medicine,Infectious Diseases Division

[3] University Hospital Center Zagreb,UCSF Weill Institute for Neurosciences, Department of Neurology

[4] University of Zagreb,Department of Neurology

[5] School of Medicine,Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat)

[6] Moscow State Public Healthcare InsCity Clinical Hospital 24,undefined

[7] Research Institute of the McGill University Health Centre,undefined

[8] University of California San Francisco,undefined

[9] First Saint Petersburg State Medical University,undefined

[10] Novartis Pharmaceuticals Corporation,undefined

[11] Novartis Pharma B.V.,undefined

[12] Novartis Healthcare Private Limited,undefined

[13] Hospital Universitari Vall d’Hebron,undefined

[14] School of Public Health at Oregon Health and Science University,undefined

来源：

Neurology and Therapy | 2022年 / 11卷

关键词：

ALITHIOS; Anti-CD20 therapy; B-cell therapy; COVID-19; Ofatumumab; Post-marketing; Relapsing multiple sclerosis; SARS-CoV-2; Vaccination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：741 / 758

页数：17

共 50 条

[31] Rare post-vaccination complications: onset of relapsing-remitting multiple sclerosis after COVID-19 vaccination - case reports and literature review
Kyc, Joanna
Bartosik-Psujek, Halina
AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (04): : 238 - 244
[32] Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
Tallantyre, Emma C.
Scurr, Martin J.
Vickaryous, Nicola
Richards, Aidan
Anderson, Valerie
Baker, David
Chance, Randy
Evangelou, Nikos
George, Katila
Giovannoni, Gavin
Harding, Katharine E.
Hibbert, Aimee
Ingram, Gillian
Jolles, Stephen
Jones, Meleri
Kang, Angray S.
Loveless, Samantha
Moat, Stuart J.
Robertson, Neil P.
Rios, Francesca
Schmierer, Klaus
Willis, Mark
Godkin, Andrew
Dobson, Ruth
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
[33] Relapsing polychondritis after COVID-19 vaccination
Ito, Koki
Ogawa, Takunori
Igarashi, Shunya
Miyai, Kosuke
Sato, Kimiya
Kawana, Akihiko
Kimizuka, Yoshifumi
RESPIROLOGY CASE REPORTS, 2024, 12 (09):
[34] Risk and outcomes of COVID-19 in patients with multiple sclerosis
Moreno-Torres, Irene
Meca Lallana, Virginia
Costa-Frossard, Lucienne
Oreja-Guevara, Celia
Aguirre, Clara
Alba Suarez, Elda Maria
Gomez Moreno, Mayra
Borrega Canelo, Laura
Sabin Munoz, Julia
Aladro, Yolanda
Carcamo, Alba
Rodriguez Garcia, Elena
Cuello, Juan Pablo
Monreal, Enric
Sainz de la Maza, Susana
Perez Parra, Fernando
Valenzuela Rojas, Francisco
Lopez de Silanes de Miguel, Carlos
Casanova, Ignacio
Martinez Gines, Maria Luisa
Blasco, Rosario
Orviz Garcia, Aida
Villar-Guimerans, Luisa Maria
Fernandez-Dono, Guillermo
Elvira, Victor
Santiuste, Carmen
Espino, Mercedes
Garcia Dominguez, Jose Manuel
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (11) : 3712 - 3721
[35] Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab
Ziemssen, Tjalf
Groth, Marie
Ettle, Benjamin
Bopp, Tobias
VACCINES, 2022, 10 (12)
[36] Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
Czarnowska, Agata
Tarasiuk, Joanna
Zajkowska, Olga
Wnuk, Marcin
Marona, Monika
Nowak, Klaudia
Slowik, Agnieszka
Jamroz-Wisniewska, Anna
Rejdak, Konrad
Lech, Beata
Popiel, Malgorzata
Rosciszewska-Zukowska, Iwona
Perenc, Adam
Bartosik-Psujek, Halina
Swiderek-Matysiak, Mariola
Siger, Malgorzata
Ciach, Agnieszka
Walczak, Agata
Jurewicz, Anna
Stasiolek, Mariusz
Kania, Karolina
Dyczkowska, Klara
Kalinowska-Lyszczarz, Alicja
Galus, Weronika
Walawska-Hrycek, Anna
Krzystanek, Ewa
Chojdak-Lukasiewicz, Justyna
Ubysz, Jakub
Pokryszko-Dragan, Anna
Kapica-Topczewska, Katarzyna
Chorazy, Monika
Bazylewicz, Marcin
Mironczuk, Anna
Kulikowska, Joanna
Kochanowicz, Jan
Bialek, Marta
Stolarz, Malgorzata
Kubicka-Baczyk, Katarzyna
Niedziela, Natalia
Warmus, Pawel
Adamczyk-Sowa, Monika
Podlecka-Pictowska, Aleksandra
Nojszewska, Monika
Zakrzewska-Pniewska, Beata
Jasinska, Elzbieta
Zaborski, Jacek
Milewska-Jedrzejczak, Marta
Zwiernik, Jacek
Zwiernik, Beata
Potemkowski, Andrzej
FRONTIERS IN NEUROLOGY, 2022, 13
[37] The psychological impact of the COVID-19 pandemic on people with multiple sclerosis
Vacaras, Vitalie
Nistor, Cristina
Schiopu, Andra Maria
Vacaras, Cristiana
Marin, Gheorghe-Eduard
Muresanu, Dafin F.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76
[38] COVID-19 and Health Outcomes in People with Multiple Sclerosis: A Population-Based Study in Italy
Gnavi, Roberto
Eboli, Ilenia
Alboini, Paolo Emilio
D'Alfonso, Sandra
Picariello, Roberta
Costa, Giuseppe
Leone, Maurizio
LIFE-BASEL, 2023, 13 (05):
[39] Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
Stanikic, Mina
Twomey, Eric
Puhan, Milo A.
Kamm, Christian P.
Salmen, Anke
Ajdacic-Gross, Vladeta
Zecca, Chiara
Gobbi, Claudio
von Wyl, Viktor
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
[40] Case report: First manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination
Czarnowska, Agata
Kapica-Topczewska, Katarzyna
Tarasow, Eugeniusz
Tarasiuk, Joanna
Chorazy, Monika
Kochanowicz, Jan
Kulakowska, Alina
FRONTIERS IN NEUROLOGY, 2023, 14

← 1 2 3 4 5 →